A detailed history of Voya Investment Management LLC transactions in Siga Technologies Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 16,539 shares of SIGA stock, worth $125,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,539
Previous 19,639 15.78%
Holding current value
$125,531
Previous $109,000 29.36%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$4.51 - $8.92 $13,981 - $27,652
-3,100 Reduced 15.78%
16,539 $141,000
Q4 2023

Feb 14, 2024

BUY
$4.82 - $6.25 $3,349 - $4,343
695 Added 3.67%
19,639 $109,000
Q2 2023

Aug 14, 2023

BUY
$5.0 - $6.31 $4,020 - $5,073
804 Added 4.43%
18,944 $95,000
Q2 2022

Aug 15, 2022

SELL
$6.5 - $13.68 $14,209 - $29,904
-2,186 Reduced 10.75%
18,140 $210,000
Q4 2021

Feb 14, 2022

SELL
$6.96 - $9.26 $6,806 - $9,056
-978 Reduced 4.59%
20,326 $153,000
Q2 2021

Aug 16, 2021

SELL
$6.1 - $7.58 $28,236 - $35,087
-4,629 Reduced 17.85%
21,304 $134,000
Q1 2021

May 17, 2021

BUY
$6.3 - $7.71 $11,629 - $14,232
1,846 Added 7.66%
25,933 $169,000
Q4 2020

Feb 16, 2021

BUY
$6.39 - $7.76 $19,764 - $24,001
3,093 Added 14.73%
24,087 $175,000
Q2 2020

Aug 14, 2020

SELL
$4.55 - $6.19 $41,072 - $55,877
-9,027 Reduced 30.07%
20,994 $124,000
Q4 2019

Feb 14, 2020

BUY
$4.34 - $5.86 $34,637 - $46,768
7,981 Added 36.21%
30,021 $143,000
Q4 2018

Feb 14, 2019

BUY
$4.77 - $7.9 $8,581 - $14,212
1,799 Added 8.89%
22,040 $174,000
Q3 2018

Nov 14, 2018

BUY
$6.03 - $8.34 $8,122 - $11,233
1,347 Added 7.13%
20,241 $139,000
Q2 2018

Aug 14, 2018

BUY
$5.89 - $7.29 $111,285 - $137,737
18,894 New
18,894 $112,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $554M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.